Factors influencing compliance in schizophrenia patients
- PMID: 14680413
Factors influencing compliance in schizophrenia patients
Abstract
Scientifically, compliance can be expressed as the ratio between an observed treatment behavior and given treatment standards. Although the factors that influence compliance often overlap or influence each other, it is possible to differentiate between factors that are related to the patient, the patient's environment, the treating clinician, and treatment itself. Although this differentiation is in some ways artificial, it may aid the practicing clinician in assessing the various reasons why a particular patient is likely to develop or has already developed compliance problems. The fact that a number of circumstances and parties are involved in the multifaceted issue of compliance makes it evident that patients must never be solely blamed for compliance problems. Despite the fact that compliance behavior is difficult to study from a methodological point of view, the scientific information available to date does provide many important leads for the engaged clinician to prevent and manage compliance problems.
Similar articles
-
[Which factors modify drug-compliance?].Psychiatr Prax. 1995 Nov;22(6):228-30. Psychiatr Prax. 1995. PMID: 8570752 German.
-
Overview of partial compliance.J Clin Psychiatry. 2003;64 Suppl 16:3-9. J Clin Psychiatry. 2003. PMID: 14680412 Review.
-
[Schizophrenic patient's constant refusal of psychotropic medication--case report and psychodynamic remarks].Psychiatr Pol. 2007 Jul-Aug;41(4):551-60. Psychiatr Pol. 2007. PMID: 18046985 Polish.
-
[Compliance problems in treatment of schizophrenic patients].Wien Med Wochenschr. 1998;148(11-12):281-3. Wien Med Wochenschr. 1998. PMID: 9746971 Review. German.
-
[Noncompliance--a typical problem in psychiatric patients. Individual, social and illness-specific factors].Fortschr Med. 1998 Jan 30;116(3):28-30. Fortschr Med. 1998. PMID: 9522542 German. No abstract available.
Cited by
-
Medication Adherence Using Electronic Monitoring in Severe Psychiatric Illness: 4 and 24 Weeks after Discharge.Clin Psychopharmacol Neurosci. 2019 May 31;17(2):288-296. doi: 10.9758/cpn.2019.17.2.288. Clin Psychopharmacol Neurosci. 2019. PMID: 30905129 Free PMC article.
-
Evaluation of treatment adherence in outpatients with schizophrenia.Ind Psychiatry J. 2017 Jul-Dec;26(2):215-222. doi: 10.4103/ipj.ipj_24_17. Ind Psychiatry J. 2017. PMID: 30089972 Free PMC article.
-
Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry.Ther Adv Drug Saf. 2013 Apr;4(2):63-71. doi: 10.1177/2042098612474681. Ther Adv Drug Saf. 2013. PMID: 25083252 Free PMC article.
-
Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.Psychopharmacology (Berl). 2006 Aug;187(2):229-36. doi: 10.1007/s00213-006-0413-4. Epub 2006 May 19. Psychopharmacology (Berl). 2006. PMID: 16710714
-
Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period.Psychopharmacology (Berl). 2004 Sep;175(2):215-9. doi: 10.1007/s00213-004-1801-2. Epub 2004 Feb 4. Psychopharmacology (Berl). 2004. PMID: 14760515
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical